Tetrapeptide derived inhibitors of complexation of a class II MHC: the peptide backbone is not inviolate.
Major histocompatabilty (MHC) proteins rely heavily on peptide backbone recognition for ligation. Nonetheless, modifications to the polyamide backbone of a tetrapeptide ligand can be made without abrogating binding.